Xeloda is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Capecitabine.
| Product ID | 53808-0411_15601703-7442-48f3-89f4-44fef66b7514 | 
| NDC | 53808-0411 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Xeloda | 
| Generic Name | Capecitabine | 
| Dosage Form | Tablet, Film Coated | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2009-07-01 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020896 | 
| Labeler Name | State of Florida DOH Central Pharmacy | 
| Substance Name | CAPECITABINE | 
| Active Ingredient Strength | 500 mg/1 | 
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] | 
| NDC Exclude Flag | E | 
| Listing Certified Through | 2017-12-31 | 
| Marketing Start Date | 2009-07-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020896 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2009-07-01 | 
| Inactivation Date | 2019-10-21 | 
| Ingredient | Strength | 
|---|---|
| CAPECITABINE | 500 mg/1 | 
| SPL SET ID: | a732b303-9bbd-42ba-a7c5-61c21629ba93 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0004-1100 | Xeloda | capecitabine | 
| 0004-1101 | Xeloda | capecitabine | 
| 53808-0411 | Xeloda | Xeloda | 
| 0054-0271 | Capecitabine | Capecitabine | 
| 0054-0272 | Capecitabine | Capecitabine | 
| 0093-7473 | Capecitabine | Capecitabine | 
| 0093-7474 | Capecitabine | Capecitabine | 
| 0378-2511 | Capecitabine | capecitabine | 
| 0378-2512 | Capecitabine | capecitabine | 
| 16714-467 | CAPECITABINE | CAPECITABINE | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  XELODA  75241696  2200434 Live/Registered | Hoffmann-La Roche Inc. 1997-02-13 |